The end of the year is a natural time to reflect on the past and look forward to the future, and this year at Markey, that happened to coincide with a visit from our External Advisory Board (EAB) earlier this month. Our EAB serves an important purpose – their existence is mandated by our National Cancer Institute designation, and their purpose is to guide Markey toward becoming an even better NCI designated center in every way possible.
Read more »
Read more »
Read more »
Read more »
Read more »
Read more »
Read more »
Read more »
Read more »
Read more »
Read more »
Read more »
View all Spotlights »
LEXINGTON, Ky. (April 16, 2015) – The University of Kentucky Markey Cancer Center announced today that St. Claire Regional Medical Center in Morehead, Ky., has joined the Markey Cancer Center Research Network, a newly launched initiative conducting high priority cancer research through a network of collaborative centers with expertise in the delivery of cancer care and conduct of research studies.
Thousands of patients across eastern Kentucky will have close-to-home access to innovative clinical research studies in the treatment and epidemiology of cancer as well as research studies in the prevention and early detection of cancer.
The team at St. Claire Regional Medical Center was invited to participate based on their previous experience in conducting oncology research. St. Claire has participated in research with Markey for more than 10 years, enrolling more than 120 patients from seven surrounding counties in nearly 20 different cancer clinical studies in that time. St. Claire’s clinical research studies included those initiated at UK in priority areas of lung cancer screening and early detection, smoking cessation, treatment therapies for lung cancer, and environmental risk factors for lung cancer.
St. Claire’s long-standing oncology research portfolio will expand as a result of joining the Markey Research Network. Clinical research studies currently open at St. Claire include a study to identify the best approaches to help cancer patients quit smoking which will help to improve their response to cancer treatments, with studies coming soon in lung cancer screening and survivorship.
“St. Claire continually works to provide an advanced level of healthcare to the 160,000 plus people in our service area,” said Mark J. Neff, president/CEO of St. Claire Regional Medical Center. The unfortunate truth is that Eastern Kentucky faces some of the highest rates of cancer incidence and mortality in the nation which is why St. Claire is so excited to join the Markey Cancer Center Research Network in the battle to reduce cancer deaths in our region by offering close-to-home access to some of the most advanced clinical cancer trial treatments available.”
Clinical research studies are key to developing new methods to prevent, detect and treat cancer, and most treatments used today are the results of previous clinical studies. These may include studies in which patients who need cancer treatment receive their therapy under the observation of specially trained cancer doctors and staff. Patients who volunteer for cancer treatment studies will either receive standard therapy or a new treatment that represents the researchers’ best new ideas for how to improve cancer care.
The portfolio of available clinical research studies for each Markey Research Network member will be targeted, focusing both on the areas with the highest burden of disease, and the types of cancers that most affect these overburdened regions. Appalachia has some of the highest rates of cancer incidence and mortality in the country, especially for lung, colorectal, and cervical cancers.
As a member of the Markey Research Network, the physicians at St. Claire Regional Medical Center will offer the opportunity to consider participation in clinical research studies to their patients, with the patients remaining under their direct care and closer to home during their treatment.
"Being able to offer not only our own trials on site, but also major NCI trials, is a huge benefit to the members of our Research Network," said Dr. Mark Evers, director of the UK Markey Cancer Center. "The patients who chose to enroll in one of these trials at St. Claire should be assured that they are receiving the latest, best treatment options for their disease, with the added benefit of staying much closer to their own support system at home."
By disseminating Markey's clinical research studies across the region, the collaborative Research Network will offer better, more progressive treatment options to patients without the burden of traveling away from home and their physicians.
"Clinical research is the best way to advance cancer treatment protocols and move forward with the most effective new therapies," said Dr. Tim Mullett, medical director of the Markey Cancer Center Research Network. "As the only NCI-designated cancer center serving the Appalachian region of Kentucky, we have an obligation to address the most devastating cancers in this area by continually improving cancer prevention, detection, and treatments. The Markey Research Network will play a vital role in improving the grim cancer mortality rates in our region."
To be invited into the Markey Cancer Center Research Network, medical centers must demonstrate a capacity to deliver the highest caliber of clinical expertise and demonstrate quality work in clinical research and complying with federal regulations. Other medical centers are expected to join the Research Network in the coming months.
MEDIA CONTACT: Allison Perry, (859) 323-2399 or email@example.com
LEXINGTON, Ky. (April 3, 2015) – Scott Logdon of Salvisa, Ky., seldom needed to visit the doctor. But in September 2012, a troublesome sore throat prompted him to make a rare visit to his primary care physician. Expecting a diagnosis of strep, he got some far worse news.
"I just thought it was strep throat," Logdon said. "It turned out to be leukemia."
Logdon was immediately referred to the University of Kentucky Markey Cancer Center, where he was officially diagnosed with acute myeloid leukemia (AML), a type of cancer that affects the blood and bone marrow.
Because this type of cancer can worsen quickly, treatment began right away. Logdon underwent a rigorous round of chemotherapy at Markey, getting his infusion nonstop 24 hours a day for seven straight days.
The chemo put him into temporary remission. But further testing suggested that Logdon's cancer was likely to return at some point. While taking the “wait and see” approach was an option, it was risky.
“Statistically speaking, in high-risk patients like Scott, the cancer is probably going to come back,” said Dr. Greg Monohan, the Markey hematologist/oncologist who treated Logdon. “And if you wait and see if the cancer returns, the chemo may not take as well the second time around.”
Monohan’s team began discussing the option of a bone marrow transplant, a procedure that replaces damaged bone marrow with healthy bone marrow stem cells. Markey performs more than 80 bone marrow transplants each year.
Logdon agreed to try the transplant in October 2012, and the search for a viable donor began. The likelihood of transplant success is highly dependent on how closely the donor’s stem cells matches the recipient’s, and usually the best donors are siblings.
However, Logdon's brother and sister were tested, and neither were a match. His medical team then contacted the National Marrow Donor Program where he could potentially be matched with an anonymous donor from one of the international bone marrow registries.
In the meantime, Logdon underwent several rounds of ‘maintenance’ chemotherapy, aimed at keeping the cancer at bay until a match was found. Every 30 days, he endured five straight days of treatment, followed by a 10-day inpatient stay at Markey where he was monitored closely by Monohan’s team. Waiting took its toll on Logdon and his family, but an unexpected phone call of encouragement from UK Men's Basketball Coach John Calipari brightened the UK fan's spirits.
"Scott has had some dark days," said Angela Logdon, Scott's wife. "But he really appreciated Coach Cal taking the time to do that."
In January 2013, Logdon and his family got the call they’d been waiting for. An ideal donor had been found: a 20-year-old male who matched 10 out of the 10 major categories of proteins that determine the likelihood of the immune system accepting the transplantation.
While walking toward the campus library one afternoon three years ago, University of Wisconsin freshman Christopher Wirz passed by tables for a national bone marrow registry donor drive. Wirz’s cousin was one of the UW students working the drive, and when he stopped to chat, she convinced him to register.
“I signed up on a whim,” Wirz said. “I just happened to be walking that way that day.”
Wirz was told that his chances of actually getting matched were slim – only about one in 100,000. But in just over a year, Wirz got the call to be a potential donor twice – the first time, he wasn’t a close enough match. But the second time, he was a perfect candidate. He agreed to do the procedure.
Wirz was flown to Washington D.C. on two separate occasions, once for major testing and evaluation, and once for the stem cell harvesting. Prior to extraction of his cells, he received a series of injections to help his stem cells move from the bone marrow to the blood. He was tested again before the extraction began to ensure his blood counts were optimal.
“You’re kind of rooting for it, even though you don’t know the person,” Wirz said. “I was really cheering for good numbers.”
His stem cells were collected using a process called leukapheresis, which is similar to giving plasma. Wirz was hooked up to an IV for several hours to extract the stem cells from his blood, filling a large IV bag with the life-saving fluid, while another IV returned the blood to his body. After his donation was complete, Wirz felt a little tired, but spent the rest of his day touring DC before heading home. He thought about where that little piece of him could be going.
“I was wondering, ‘What happens to it now?’” Wirz said. “Where is it being delivered?”
Logdon received his bone marrow transplant on Jan. 31, 2013, following one last round of chemo. After nearly four weeks in the hospital, he was allowed to go home, though he continued to have weekly checkups for many months. Logdon's strength gradually returned, and he was able to return to his job at the Woodford County Detention Center, initially working part-time, in October.
“It took about a year to feel ‘normal’ again,” Logdon said.
Unrelated hematopoietic cell donations are anonymous – and any contact between the donor/recipient remains anonymous during the first year. After that mark, direct contact is allowed if both parties consent to release their personal information. Wirz received a handful of letters thanking him for his donation – from Scott, Angela, and their four children, including one carefully scrawled by their eight-year-old son.
Curious about the family, Wirz found them on Facebook, where Angela and Scott had documented every step of his illness.
“I saw his entire journey, from diagnosis and after,” Wirz said. “He was going through this life-threatening disease, but stayed so positive throughout it.”
That included some big moments: statuses about their joy at finding a match, and the happy outcome of the procedure, where Logdon was deemed cancer-free.
“I thought, ‘That’s me!’” Wirz said. “He has a part of me growing in him, and that’s what’s helping him.”
The two communicated via Facebook for several weeks, but their first phone call came early in April 2014 -- just a few days, in fact, after the University of Kentucky Men’s Basketball Team knocked off the University of Wisconsin in the semifinal game of the NCAA tournament.
Logdon, who describes his whole family as “die-hard UK fans,” couldn’t resist making a joke to the young Wisconsin student.
“I told him, ‘You know, I knew I felt kind of bad about beating Wisconsin in the tournament,’” Scott said. “’I guess it’s because I’ve got a little Badger blood in me now!’”
Later that summer, the Logdons invited Wirz and his family to come to Kentucky for the opportunity to celebrate and thank them in person. The first meeting between donor and recipient was emotionally overwhelming.
"There were a lot of tears," Logdon said. "I didn't want to let go of him when I hugged him."
Wirz, his sister, and his mother stayed for three days, touring the area and meeting dozens of thankful friends and family. One of the tour stops included Rupp Arena, where they convinced Wirz to try an Ale8 -- and, Logdon jokes, to show off UK's basketball tradition.
"We took him to Rupp Arena to show him where championships happen," Logdon said with a laugh.
Wirz, who described the whole experience as "amazing," said seeing how beloved Logdon was in his community made the whole experience finally seem real.
"Getting to see his community, and seeing how everything would be different without him," Wirz said. "That was really overwhelming."
"He's a very giving guy," Logdon said. "You don't see many 20-year-olds like him."
Wirz, now a senior and a triple-major at UW, said he wouldn't hesitate to help out another anonymous patient in need again.
"I would do it again in a heartbeat," Wirz said.
Signing up to become a donor in the marrow registry is easy – participants only need to fill out about five minutes of paperwork and complete a set of cheek swabs.
On Monday, April 13, the UK College of Pharmacy is hosting a Be the Match registry drive at the UK Markey Cancer Center. The drive will be set up at the Combs Research Building atrium at Markey from 11 a.m. to 2 p.m. that day. If you can't make it to a local drive but would like to join the registry from home, visit Be the Match for more information.
MEDIA CONTACT: Allison Perry, 606-782-7735, firstname.lastname@example.org or Kristi Lopez, 859-323-6363 or email@example.com
Lexington, Ky. (April 2, 2015) - The Christ Hospital Health Network (TCHHN) in Cincinnati, Oh., announced today an affiliation with the University of Kentucky Markey Cancer Center, the state's first and only National Cancer Institute-designated cancer center. The affiliation will provide patients with more cancer treatment options and advanced education and research.
“We look forward to expanding healthcare choices for patients with cancer with this affiliation,” said Mike Keating, president and CEO of The Christ Hospital Health Network. “Our cancer experts will work closely with their colleagues at the UK Markey Cancer Center to advance high-quality care, with a focus on exceptional outcomes, affordable care and the finest patient and family experiences.”
“Our world-renowned physicians from the best educational institutions in the country, are critical, driving factors in our recognition, including high performing in our region by U.S. News & World Report," said Dr. Brian Mannion, medical director of oncology services at The Christ Hospital Health Network. "UK has a long-standing history as Kentucky’s top academic medical center. This affiliation will allow us to do even more for our cancer patients, particularly as we expand access to needed cancer services in Northern Kentucky.”
For the last 30 years, The Christ Hospital Health Network has been recognized as a national leader in cancer clinical trials with research and innovation that has led to breakthrough medical advances and improved outcomes. The Christ Hospital Health Network averages 30 active studies, from phase I through phase IV, and is affiliated with leading national research institutions, individuals, groups and corporations.
Through The Christ Hospital Health Network’s commitment to transforming care and expanding patient access and convenience in Northern Kentucky and across the region, patients will now have access to significant clinical cancer trials in Northern Kentucky through the UK Markey Cancer Center’s designation as a National Cancer Institute cancer center, one of only 68 cancer centers in the country and the only one in Kentucky.
“We are providing choice to our patients and their families with cancer without the stress and inconvenience of having to travel to other parts of the country,” Keating said. “Providing access to quality healthcare services where people live and work is at the heart of The Christ Hospital Health Network’s mission and is one of the key reasons we have been recognized by local consumers as the Most Preferred provider in the region for 19 consecutive years.”
"The burden of cancer in this area is huge, and reducing its impact requires collaboration and teamwork from many excellent community hospitals in the region," said Dr. Tim Mullett, director of the Markey Cancer Center Affiliate Network. "Bringing The Christ Hospital Health Network into the Markey Cancer Center Affiliate Network is another major step toward improving cancer care in Kentucky and beyond."
The affiliation provides many benefits to patients and physicians, including:
· More patient choice and convenient access
· New and innovative cancer treatments
· Cutting-edge clinical trials consultations with specialists and subspecialists
· Multidisciplinary cancer conferences, where physicians share knowledge, experience and explore new approaches to treatment
· Program support in medical oncology/hematology, pathology, molecular diagnostics, pharmacy, nursing and dietetics
· Access to the latest education and training for physicians, nurses and other caregivers
· Support for community outreach and education activities.
The Christ Hospital Health Network is the first affiliate hospital from outside the state of Kentucky. The Markey Cancer Center Affiliate Network began in 2006 and now comprises 13 hospitals:
LEXINGTON, Ky. (March 27, 2015) – Next week, KET will feature three University of Kentucky experts discussing cancer care in a set of programs that will accompany the three-part documentary series Cancer: The Emperor of All Maladies by Ken Burns.
The series, which will air March 30, 31 and April 1 at 9 p.m., is based on the Pulitzer Prize-winning book The Emperor of All Maladies: A Biography of Cancer by Siddhartha Mukherjee.
On Sunday, March 29, at 1 p.m. on KET, UK Markey Cancer Center Director Dr. Mark Evers, will appear on One to One with Bill Goodman, discussing the latest news in cancer care and research, and Markey's goals to conquer cancer in the Commonwealth. Evers' interview will air again on Monday, March 30, 12:30 a.m. on KET and Tuesday, March 31, 7:30 p.m. on KET2.
On Wednesday, April 1 at 8 p.m., two UK experts will join KET Health Three60 host Renee Shaw for a live call-in program called "Answers for Cancer." Dr. Tim Mullett, a UK HealthCare lung cancer specialist who is himself a cancer survivor, and Dr. Fran Feltner, director of the UK Center for Excellence in Rural Health, will be on the panel to take questions from viewers about cancer screening, treatment and recovery resources in Kentucky.
Other panelists include Donald Miller, director of the James Graham Brown Cancer Center at the University of Louisville, and Patrick Williams, medical director at Norton Cancer Institute in Louisville.
Viewers can submit questions to the original program via Twitter at @HealthKET, by email at firstname.lastname@example.org, or by phone at 800-753-6237. A recording of the program will air on KETKY April 6 at 9 a.m., April 10 at 11 a.m., April 11 at 4 a.m. and April 13 at 2 a.m.
LEXINGTON, Ky. (March 26, 2015) – The University of Kentucky Markey Cancer Center announced Wednesday that King's Daughters Medical Center in Ashland, Ky., has joined the Markey Cancer Center Research Network, a newly launched initiative conducting high priority cancer research through a network of collaborative centers with expertise in the delivery of cancer care and conduct of research studies.
Thousands of patients across eastern Kentucky, southern Ohio and West Virginia will have close-to-home access to innovative clinical research studies in the treatment and epidemiology of cancer as well as research studies in the prevention and early detection of cancer.
The team at King's Daughters Medical Center was invited to participate based on their previous experience in conducting oncology research. King's Daughters has participated in research with Markey for more than 25 years, enrolling more than 450 patients from nine surrounding counties in nearly 50 different cancer clinical studies in that time. Their active clinical research studies included those initiated at UK as well as national research studies sponsored by the National Cancer Institute in the National Clinical Trials Network. This long-standing oncology research portfolio will expand as a result of joining the Markey Research Network.
Dr. David Goebel, oncologist/hematologist at King's Daughters, said that this formal membership in the Markey Cancer Center Research Network would further King's Daughters' already strong relationship with the oncology researchers at UK.
"This research collaborative helps our patients with the best options to battle cancer," Goebel said. "The benefit of these studies not only can help the person with cancer, but also provide insight into treating others."
As a member of the Markey Research Network, the physicians at King's Daughters Medical Center will offer the opportunity to consider participation in clinical research studies to their patients, with the patients remaining under their direct care and closer to home during their treatment.
"Being able to offer not only our own trials on site, but also major NCI trials, is a huge benefit to the members of our Research Network," said Dr. Mark Evers, director of the UK Markey Cancer Center. "The patients who chose to enroll in one of these trials at King's Daughters should be assured that they are receiving the latest, best treatment options for their disease, with the added benefit of staying much closer to their own support system at home."
"Clinical research is the best way to advance cancer treatment protocols and move forward with the most effective new therapies," said Dr. Tim Mullett, medical director of the Markey Cancer Center Research Network. "As an NCI-designated cancer center not just serving all of Kentucky, but regions of Appalachia including West Virginia, we have an obligation to address the most devastating cancers in this area by continually improving cancer prevention, detection, and treatments. The Markey Research Network will play a vital role in improving the grim cancer mortality rates in our region."
To be invited into the Markey Cancer Center Research Network, medical centers must demonstrate a capacity to deliver the highest caliber of clinical expertise and demonstrate qualify work in clinical research and complying with federal regulations. Other medical centers are expected to join the Research Network in the coming months.
Video produced by UK Public Relations and Marketing. To view captions for this video, push play and click on the CC icon in the bottom right hand corner of the screen. If using a mobile device, click the "thought bubble" icon in the same area.
LEXINGTON, Ky. (March 19, 2015) – Singing, laughing and smiling are not words that most people would associate with a cancer treatment, but for Lexington resident Bahar Aleem, it's a common experience.
Aleem was diagnosed with breast cancer after her doctor found a small cancerous lump in her breast during an annual mammogram. After having surgery to remove the tumor, she was required to come to the University of Kentucky Markey Cancer Center weekly for chemotherapy. That's when she discovered the healing power of music therapy.
Music therapy is a specific type of complementary therapy where a board-certified music therapist provides patient-preferred music before, during, or after treatments to help a patient relax and explore new ways of thinking about their experiences. Studies indicate that music therapy can help reduce patient anxiety, lower pain perception and even reduce the amount of sedative intake needed before a procedure.
Music therapy is always conducted with the purpose of achieving therapeutic outcomes. Because there's not one specific type of music that functions the same for everyone, music is chosen carefully in order to find songs that will have the best therapeutic effect for each individual patient and/or family.
UK HealthCare has offered music therapy in many inpatient areas of the hospital since 2010. Last year, Music Therapist Jennifer Peyton was hired to treat patients at Markey, and the cancer center is able to offer this service to both its inpatients and chemotherapy outpatients.
During cancer treatments, Peyton will visit a patient's room, armed with her guitar, shakers and other musical instruments. She sings and plays for the patients and encourages them to participate with her, hoping that the music will allow them to express their emotions in a new, comfortable way.
Peyton is quick to point out that the therapy aspect of what she does is the most important part.
"We use patient-preferred music to elicit change in spiritual, cognitive, physical, and emotional domains," said Peyton. "This is not entertainment. While it can be entertaining, music therapy is not entertainment. It's therapy that uses music as a vehicle to do it."
Video Produced by UK Public Relations & Marketing. To view captions for this video, push play and click on the CC icon in the bottom right hand corner of the screen. If using a mobile device, click on the "thought bubble" in the same area.
Peyton sees Aleem regularly, and the song of choice for Aleem is "Somewhere Over the Rainbow."
"I think it takes you away from your current situation and just makes you feel normal for a little while," said Aleem. "You don't think about or worry about anything. It just takes you away and makes you feel happy."
After singing, Peyton asks Aleem a round of questions, including "What does this song do for you?" or "Where is 'over the rainbow' for you?" These are opportunities for Aleem to explore any emotions the song might have evoked.
"It's amazing how people can identify with lyrics of a song much more readily than they can express them themselves," said Peyton.
Once the music starts, Aleem's eyes light up and she begins to smile from ear to ear. Peyton plays her guitar and sings while Aleem happily sways back and forth, taps her feet, claps her hands and sings along. Even Aleem's husband joins in by playing small maracas. Because of music therapy, Aleem now looks forward to getting her treatments.
"Even though having someone sing and play to you isn't a typical event, it can help someone feel special and it normalizes things and make things not so scary and not so anxious and not so stressful," said Peyton.
Overall, Peyton says the response from patients receiving music therapy has been very positive. She looks forward to growing the program at Markey and serving even more patients from all across the state.
After experiencing its positive effects, Aleem hopes the program expands as well.
"It just kind of uplifts you and makes you feel better no matter how you feel," said Aleem. "So hopefully we will be seeing more of it."
For more information on the music therapy program at Markey Cancer Center, contact Jennifer Peyton at email@example.com.
LEXINGTON, Ky. (March 9, 2015) – Nathan Vanderford, assistant director for research at the University of Kentucky Markey Cancer Center and assistant professor in the Department of Toxicology and Cancer Biology, has a featured article on graduate education in the March 5 edition of Nature. Nature is one of the most prominent and prestigious interdisciplinary scientific journals in the world.
Vanderford co-wrote an article titled, "Wanted: Information" with Viviane Callier from the Ronin Institute for Independent Scholarship. In the piece, Vanderford and Callier examine why recent doctoral graduates are having trouble obtaining jobs. They note that doctoral students, specifically those in the science and engineering fields, are not given enough information before obtaining a higher degree and also do not receive enough information about the job market while obtaining the degree.
According to the article, "those pursuing a Ph.D. need a more accurate picture of the academic and non-academic job markets and they need it well before they graduate."
Vanderford and Callier believe that with better information, students can better prepare to enter the job market and avoid common mistakes that leave them feeling both overqualified and unqualified for positions.
To view the full article, visit Nature online.
LEXINGTON, Ky. (Feb. 25, 2015) – The National Cancer Institute recently awarded a two-year, $357,743 grant to University of Kentucky Markey Cancer Center researchers to study the role of a certain protein in aggressive cancer metastasis.
The lab of Kathleen O'Connor, professor in UK's Department of Molecular and Cellular Biochemistry, studies how tumor cells interact with their environment to make cancer more aggressive.
Specifically, O'Connor's lab studies a protein called integrin α6β4, a protein that integrates signals from its environment so that cells can respond properly and die off if they are in the wrong context. This protein can cause carcinoma cells to take on some of the worst properties of cancer, including invasion, metastasis and drug resistance.
The integrin can selectively increase the expression of genes that cause cells to become particularly invasive and metastatic through a process known as DNA demethylation, but O'Connor says they do not yet know how these specific genes can be regulated.
"Through this study, we expect that understanding how the integrin affects this process will tell us more about how specific DNA demethylation occurs, as well as how cancers can become more invasive without mutating the DNA," O'Connor said.
LEXINGTON, Ky. (Feb. 3, 2015) – The University of Kentucky Markey Cancer Center is hosting a free patient education program on clinical trials at noon, Wednesday, Feb. 4, in the atrium of Markey's Combs Research Building.
In conjunction with World Cancer Day 2015 and the Leukemia & Lymphoma Society, UK HealthCare hematologist/oncologist Dr. Greg Monohan will present information about clinical trials. Attendees will learn why clinical trials are performed and how they work, how new treatments are developed and approved, the benefits and risks of participating in a research study, how to find local clinical trials and information about the Leukemia & Lymphoma Society.
This event is free and open to the public, and it includes lunch and giveaways. For more information or to register for this event, please call Joan Scales at 859-323-1403. Free parking is available in the Markey Cancer Center lot, or visitors may park in any UK HealthCare Garage.
The Markey Cancer Center was founded in 1983 and is a dedicated matrix cancer center established as an integral part of the University of Kentucky and the UK HealthCare enterprise. In July 2013, Markey was designated by the National Cancer Institute (NCI) to receive research funding and many other opportunities available only to the nation’s best cancer centers. Markey is the only NCI-designated center in Kentucky and one of only a handful in the country.
LEXINGTON, Ky. (Feb. 2, 2015) - Starting this month, University of Kentucky Markey Cancer Center art therapist Fran Belvin will be hosting several art therapy craft sessions each month in the Whitney-Hendrickson Building.
The table is an extension of Markey's regular art therapy program, which gives patients a way to express themselves through creating a unique work of art and to also allow them to share their experience and emotions in a more comfortable environment than a typical therapy session. Although the regular art therapy sessions are mainly for patients, loved ones and staff are also welcome to join and benefit from the open art therapy craft sessions at Markey.
In February, the art table project will be making Valentine's Day-themed pillows. All sessions will be located in the Whitney-Hendrickson Building first floor lobby. The dates and times for February's events are:
· Monday, Feb. 2; noon-2 p.m.
· Wednesday, Feb. 4; 9-11 a.m.
· Friday, Feb. 6; 9-11 a.m.
Previously, Belvin has hosted art therapy "Healing Symbol" and ornament tables at Markey.
LEXINGTON, Ky. (Jan. 21, 2015) – The University of Kentucky Markey Cancer Center will host a special gala on Saturday, Feb. 7, to support its second annual Expressions of Courage exhibit this summer.
Markey's Expressions of Courage exhibit is a yearly art showcase featuring original, artistic expressions connected in some way to an experience with a cancer diagnosis, or crafted by or in memory of a Markey patient whose battle has ended. The exhibit takes place in June, which is National Cancer Survivorship Month.
The Expressions of Courage Gala will help raise funds to support the exhibit, which allows patients and family members to showcase their original art, dance, poetry and music in a celebratory environment.
The Gala will take place at the DoubleTree Suites at Hilton Hotel at 2601 Richmond Road
in Lexington. The gala's events include:
6 p.m. Appetizers, cocktails, and a silent auction
6:30 p.m. Musical performances by Dr. Jay "Zwisch" Zwischenberger and Kayla Smith
7:30 p.m. Buffet dinner
8:45 p.m. Entertainment by the Donnie Brooks Band.
Tickets for the Gala are $50. To purchase tickets, visit ukmarkey.org/markeyevents or buy in person at the Markey Administrative Offices on the first floor of the Ben F. Roach Building at the Markey Cancer Center.
LEXINGTON, Ky. (Dec. 22, 2014) – UK HealthCare has temporarily amended its inpatient hospital visitation policy to be proactive in helping protect the health and well-being of patients and health care workers during this flu season. Visitation restrictions are in effect as of 7 a.m. Monday, Dec. 22.
The measures include:
o No visitors under the age of 12
o No visitors with any symptoms of flu-like illness
o Only two visitors will be permitted in a patient’s room at one time
o Visitors may be issued masks or other protective clothing for use when visiting
o Additional restrictions may be in place in special care units such as women's and children’s units, critical care and oncology units.
o Compassionate visitation exceptions will be made on a case-by-case basis.
"Due to an increasing number of flu cases in Kentucky, UK HealthCare will be instituting these procedures designed to help protect patients, visitors and staff from exposure to the flu and are in effect at all UK HealthCare inpatient units including University of Kentucky Chandler Hospital, Kentucky Children's Hospital, UK Good Samaritan Hospital and Eastern State Hospital," said Kim Blanton, enterprise director for infection prevention and control at UK HealthCare.
Last week, the Centers for Disease Control and Prevention reported that the flu was widespread in 29 of the 54 states and territories that it tracks -- including Kentucky. This time last year, it was widespread in only four.
It is still recommended everyone six months of age and older who hasn't received a flu shot yet, receive one, Blanton said. "A flu vaccine is still the first and best way to prevent influenza," she said.
Flu symptoms can include fever, cough, sore throat, runny or stuffy nose, body aches, headache, chills and fatigue. Flu antiviral drugs are available and work best for treatment when they are started within two days of getting sick. However, starting them later can still be helpful, especially if the sick person has a high risk health condition or is very sick from the flu.
MEDIA CONTACT: Kristi Lopez, 859-806-0445 or firstname.lastname@example.org
LEXINGTON, Ky. (Dec. 15, 2014) – Two University of Kentucky researchers have been awarded $1.62 million in grants through special interest projects from the Centers for Disease Control and Prevention (CDC).
The grants fund projects that focus on methods for improving the dire cancer statistics in Appalachian Kentucky, which has some of the highest rates of cancer incidence and mortality in the country.
Robin Vanderpool, an assistant professor in the Department of Health Behavior in the UK College of Public Health, was awarded a 5-year, $1.37 million grant to fund the Appalachian Center for Cancer Education, Screening, and Support (ACCESS), a collaboration between the University of Kentucky's Rural Cancer Prevention Center (RCPC) and the national Cancer Prevention and Control Research Network (CPCRN).
CPCRN is supported by both CDC and the National Cancer Institute (NCI). ACCESS will work to accelerate the adoption of evidence-based cancer prevention and control programs in Appalachian Kentucky communities and reduce the cancer burden in these underserved populations. The goal of the project is to use existing primary care resources in efficient and effective ways to promote guideline-recommended cancer screenings and improve overall health in the region.
Specifically, ACCESS will conduct a regional research project with White House Clinics, a federally qualified health center that serves a medically underserved and high-poverty region in Appalachian Kentucky. The project will design, implement, and evaluate a proactive officer encounter (POE) intervention effort in eight community health centers, which will provide a systematic approach to offering breast, cervical, colorectal and lung cancer screening services at every office encounter for eligible patients.
Bin Huang, an assistant professor in the Division of Cancer Biostatistics in the Department of Biostatistics, UK College of Public Health, was awarded a 2-year, $250,000 grant to improve Kentucky Cancer Registry (KCR) data through ancillary data linkage. The main goal of Huang's project is to establish groundwork and examine the feasibility for the development of a sustainable Kentucky Cancer Quality and Outcome Research Data System, with the goal of improving the quality of care for Kentuckians with cancer.
The project seeks to generate enhanced KCR data, specifically in Appalachian Kentucky, by linking with external sources such as Medicare, Medicaid, and private insurers; populating treatment summaries for breast and colorectal cancers; and conducting patterns of care research in cancer survival disparities for these types of cancers in Appalachian and non-Appalachian populations.
“These projects are a great example of the interdisciplinary work of investigators in the College of Public Health and Markey Cancer Center that spans the cancer prevention and control continuum, from screening interventions to surveillance, to remedy the cancer disparities faced by residents of Appalachian Kentucky,” said Margaret McGladrey, assistant dean for research in the UK College of Public Health.
Federal funds from the CDC and NCI financed 100 percent of the costs for these special interest projects; no non-governmental sources contributed to the funding.
Video by UK Public Relations.
LEXINGTON, Ky. (Dec. 10, 2014) – With a table stacked full of pre-cut foam patterns, markers, stamps, and various creative accoutrements, University of Kentucky Markey Cancer Center Art Therapist Fran Belvin is determined to bring a little holiday cheer to the patients and visitors coming through Markey's outpatient clinics.
As patients and visitors walk past her table, many stop to check it out, hesitant. Belvin and her student assistant, Kalin Wilson, welcome them with broad smiles and a simple question: "Would you like to decorate an ornament today?"
Those that say yes sit down and begin to work. Once their creative project is under way, many of the participants begin to tell Belvin about themselves: the treatment they or their loved ones are going through, their struggles, their backstories.
As Belvin notes, there's something about sitting down to work on a creative project that helps people open up and share their feelings. She sees similar reactions from the chemotherapy patients she works with on a daily basis.
"Art therapy is a way for patients to express themselves… a way to explore fears, hopes, and talk about their cancer journey," Belvin said. "Making art and talking about it feels a little less formal, less threatening than if a counselor were to sit down and say, 'Tell me how you're feeling today.'"
Belvin, who began working for Markey as an art therapist in June, spends most of her time visiting patients one-on-on in the chemotherapy suite – or "curtain-to-curtain," as she describes it.
"In addition to helping patients process the emotional effects of their illness, it's also a way to relax and reduce stress," Belvin said. "Chemotherapy can be uncomfortable, it can be boring, and it can be frightening – especially at first. Getting engaged in a creative activity is not only a fun distraction, it puts people in touch with their strengths and increases their positive feelings. In fact, research has shown that art making significantly reduces the stress hormones in the brain and elevates mood."
The ornament table is the second "art event" she's held at the cancer center. Earlier this year, she hosted a "Healing Symbol" table, where she invited participants to create their own personal symbol that represented healing.
Because art therapy is a new addition to the UK Markey Cancer Center's complementary therapy services, Belvin hopes her art events will help spread the word about the services she offers, not just to patients and visitors, but also to healthcare providers who may like to refer their patients to her. Research shows that "creative arts" therapies – including music, art, dance, drama, and writing – significantly reduces anxiety, depression, and pain and improved the quality of life in cancer patients.
Ultimately, Belvin's current ornament table is meant to bring a little levity and stress relief to those passing through the Markey Cancer Center's doors.
"I hope to offer a little bit of brightness while you're going to the doctor's office, where you're not expecting to have a fun, relaxing thing to do," Belvin said. "So I'm hoping this provides a way for people to kind of relax and have a little fun in the middle of their day."
Belvin is hosting two more art therapy ornament-making tables at Markey, both in the first floor lobby of the Whitney-Hendrickson Building. The table will be up again 1-2:30 p.m. today and next Wednesday, Dec. 17, 1-2:30 p.m. Patients, visitors and staff are all welcome to attend and participate.
MEDIA CONTACT: Allison Perry (859) 323-2399 or email@example.com
LEXINGTON, Ky. (Dec. 8, 2014) – University of Kentucky College of Medicine faculty member in behavioral science and Director of the Kentucky LEADS Collaborative Dr. Jamie Studts was featured during the "UK at the Half" that aired during the UK vs. Providence College basketball game, broadcast on the radio Nov. 30.
The Kentucky LEADS Collaborative received a three-year, $7 million grant from the Bristol-Myers Squibb Foundation's Bridging Cancer Care Initiative. Kentucky has more cases of lung cancer than any other state and its lung cancer mortality rate is 50 percent higher than the national average. The collaborative includes the UK Markey Cancer Center, The University of Louisville's James Graham Brown Cancer Center and the Lung Cancer Alliance. The grant funds a three-phase project supporting an increase in primary care provider information, a lung cancer survivorship care initiative and new opportunities in lung cancer screening.
"UK at the Half" airs during the halftime of each UK football and basketball game broadcast and is hosted by Carl Nathe of UK Public Relations and Marketing.
To hear the "UK at the Half" interview click on the play button below. To view a transcript for the Nov. 30 "UK at the Half" interview, click here.
Read the latest annual report »
800 Rose St.
University of Kentucky
Lexington, KY 40536
866-340-4488 (toll free)
connected with Markey. Become a fan of Markey's Facebook. Stay up-to-date on
community events, programs, treatments, research, new physicians and more.
© University of Kentucky, Lexington, Kentucky, USA | An Equal Opportunity University